KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late ...

Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone ...

H3, to be featured in two poster presentationsData facilitate initial understanding of AKY-2519 biodistribution and predicted ...

Here's the latest reporting from the WGLT Newsroom following severe storms and tornadoes that walloped McLean County on ...

Internal and public government records reveals how the federal government has spent $60 million on contracts with the ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Detailed price information for Medicenna Therapeutics Corp (MDNA-T) from The Globe and Mail including charting and trades.

This news release contains forward-looking information about expected future events that is subject to risks and assumptions set out in the ...

Stacker compiled data on the top feature-length films from the past 100 years, crowning a champion for each year using ...

For this Giz Asks, we asked experts on lunar science, astronaut health, and aerospace engineering what they will learn from ...

ASCEND Phase 1/2 global clinical trial ongoing, evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor ...